Halogenated triptolide derivatives as immunomodulators and anticancer agents

Details for Australian Patent Application No. 2004216115 (hide)

Owner Pharmagenesis, Inc.

Inventors Dai, Dongcheng; Musser, John H.

Agent FB Rice

Pub. Number AU-A-2004216115

PCT Pub. Number WO2004/075853

Priority 60/449,976 25.02.03 US; 10/786,663 24.02.04 US

Filing date 25 February 2004

Wipo publication date 10 September 2004

International Classifications

A61K 031/34 - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/075853 Priority application(s): WO2004/075853

17 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004216121-Powered toothbrush with improved ergonomics

2004216110-Construction of a deafness gene chip